Take orally, preferably with or after food, to minimize gastrointestinal discomfort. Shake well before use. Use a measuring spoon or cup for accurate dosing.

Mefenamic Acid inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, which are responsible for the synthesis of prostaglandins. Prostaglandins mediate pain, inflammation, and fever, so by inhibiting their synthesis, Mefenamic Acid reduces these symptoms.

• •Hypersensitivity to Mefenamic Acid, aspirin, or other NSAIDs
• •Active gastrointestinal ulceration, inflammation, or bleeding
• •Severe renal or hepatic impairment
• •Severe heart failure
• •Patients with a history of aspirin-induced asthma, urticaria, or allergic-type reactions
• •Third trimester of pregnancy

Store below 30°C in a dry place, away from light and moisture. Do not freeze. Keep out of reach of children.

Symptoms of overdose may include lethargy, drowsiness, nausea, vomiting, epigastric pain, and gastrointestinal bleeding. Rarely, hypertension, acute renal failure, respiratory depression, and coma may occur. Management: Gastric lavage, activated charcoal, and symptomatic and supportive treatment. There is no specific antidote.

Pregnancy: Contraindicated in the third trimester due to potential adverse effects on the fetal cardiovascular system (premature closure of ductus arteriosus). Use in early pregnancy only if clearly needed and benefit outweighs risk. Lactation: Mefenamic Acid is excreted in breast milk in small amounts. Use with caution during breastfeeding; consult a doctor.